| Literature DB >> 21362204 |
Marianne S Desmedt1, Yolande L de la Kethulle, Myriam I Deveugele, Emmanuel A Keirse, Dominique J Paulus, Johan J Menten, Steven R Simoens, Paul J Vanden Berghe, Claire M Beguin.
Abstract
BACKGROUND: Hospital care plays a major role at the end-of-life. But little is known about the overall size and characteristics of the palliative inpatient population. The aim of our study was to analyse these aspects.Entities:
Year: 2011 PMID: 21362204 PMCID: PMC3052175 DOI: 10.1186/1472-684X-10-2
Source DB: PubMed Journal: BMC Palliat Care ISSN: 1472-684X Impact factor: 3.234
Prevalence of palliative inpatients
| N | Palliative Patients | Non Palliative Patients | p-value | ||
|---|---|---|---|---|---|
| Type of beds | Surgery | 727 | 16 (2.2%) | 711(97.8%) | p ≤ 0,001 |
| Rehabilitation | 488 | 22 (4.5%) | 466 (95.5%) | ||
| Medicine | 1015 | 134 (13.2%) | 881 (86.8%) | ||
| Geriatric | 409 | 77 (18.8%) | 332 (81.2%) | ||
| Region | Flanders | 624 | 49 (7.9%) | 575 (92.1%) | p ≤ 0,001 |
| Wallonia | 692 | 56 (8.1%) | 636 (91.9%) | ||
| Brussels | 534 | 85 (15.9%) | 449 (84.1%) | ||
| Palliative care unit | With | 1614 | 166 (10.3%) | 1448 (89.7%) | p = 0.0610 |
| Without | 1025 | 83 (8.1%) | 942 (91.9%) | ||
| Social status | Public | 1111 | 96 (8.6%) | 1005 (91.4%) | p = 0.2338 |
| Private | 1528 | 153 (10.0%) | 1375 (90.0%) | ||
Distribution of primary diagnoses
| Cancer diagnoses | 128 (51.4%) |
|---|---|
| Solid tumour | 108 (43.4%) |
| Haematological cancer | 19 (7.6%) |
| Non-cancer diagnoses | 121 (48.6%) |
| Dementia | 32 (12.9%) |
| Stroke | 17 (6.8%) |
| Organ system failure | 50 (20.0%) |
| Cardiac failure | 16 (6.4%) |
| Respiratory failure | 16 (6.4%) |
| Hepatic failure | 13 (5.2%) |
| Renal failure | 5 (2.0%) |
| Other diseases | 40 (16.0%) |
| Neurological diseases | 8 (3.2%) |
| Vascular diseases | 6 (2.4%) |
| Infectious diseases | 2 (0.8%) |
| Others | 6 (2.4%) |
| Total | 249 (100%) |
Figure 1Age distributions of palliative patients by diagnostic group. The first bar represents the distribution of age of all palliative patients whatever the disease. The others display the distribution of age for the most frequent underlying diseases.
Distribution of estimated life expectancy
| < 7 days | 10 (4.1%) | 79 (32.5%) |
|---|---|---|
| > 1 and ≤ 4 weeks | 24 (9.9%) | |
| > 1 and ≤ 3 months | 45 (18.5%) | |
| > 3 and ≤ 6 months | 40 (16.5%) | 97 (40.0%) |
| > 6 and ≤ 12 months | 57 (23.5%) | |
| > 1 and ≤ 5 years | 62 (25.5%) | 67 (27.5%) |
| > 5 years | 5 (2.0%) | |
| Total | 243 (100%) | |
Figure 2Survival prognosis according to disease. The first bar represents the distribution of life expectancy of all palliative patients whatever the disease. The others display the distribution of survival prognosis for the most frequent underlying diseases.
Physicians' expectations from the treatment plan
| Life prolongation | Improvement of comfort | |||
|---|---|---|---|---|
| Pathology | Cancer | 32 (49.2%) | 94 (52.5%) | p = 0.6501 |
| Non-cancer | 33 (50.8%) | 85 (47.5%) | ||
| Age | < 75 years | 37 (56.9%) | 72 (40.2%) | p = 0.0204 |
| ≥ 75 years | 28 (43.1%) | 107 (59.8%) | ||
| Prognosis | ≤ 3 months | 5 (7.7%) | 73 (40.8%) | p < 0.0001 |
| > 3 months | 56 (86.2%) | 104 (58.1%) | ||
| ≤ 1 year | 33 (50.8%) | 141 (78.8%) | p = 0.0019 | |
| > 1 year | 28 (43.1%) | 36 (20.1%) | ||
Prognosis and treatment excluded
| Prognosis | ||||||
|---|---|---|---|---|---|---|
| Treatments excluded | < 7 days | 1-4 weeks | 1-3 months | 3-6 months | 6-12 months | > 1 year |
| Cardiac resuscitation | 100% | 91.7% | 81.8% | 72.5% | 63.2% | 67.2% |
| Transfer to intensive care unit | 100% | 95.5% | 72.7% | 57.9% | 58.2% | 56.5% |
| Treatment specific to the causative disease | 90.0% | 52.2% | 54.8% | 30.8% | 28.6% | 33.3% |
| Artificial nutrition | 90.0% | 73.9% | 47.6% | 54.1% | 40.0% | 36.1% |
| Antibiotics | 80.0% | 30.4% | 4.4% | 0 | 1.8% | 3.1% |
| Transfusion | 80.0% | 54.2% | 20.5% | 13.5% | 9.1% | 5.0% |